The identified p.R35L mutation was previously reported in 2 cases of myeloid neoplasms [74, 29], but to the best of our knowledge, U2AF1 has never been associated with T-ALL prior to this study. This evidence concerns the gene U2AF1 and myeloid neoplasm.